ホーム › 子宮内膜がん › バージニア › Arlington
Arlington、VAにおける子宮内膜がんの臨床試験
Arlingtonとその周辺地域（約30マイル以内）の拠点で、子宮内膜がんに関する39件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
被験者募集中第2相
- Inova Fairfax Hospital, Falls Church · 4マイル先
- Inova Schar Cancer Institute, Fairfax · 11マイル先
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Inova Schar Cancer Institute, Fairfax · 11マイル先
- NEXT Virginia, Fairfax · 11マイル先
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
被験者募集中第1相
- Site 04, Fairfax · 11マイル先
Study of AVZO-021 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- Avenzo Therapeutics Recruiting Site, Fairfax · 11マイル先
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
被験者募集中第3相
- Inova Schar Cancer Institute ( Site 6003), Fairfax · 11マイル先
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · 11マイル先
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
被験者募集中第1/2相
- NEXT Oncology, Fairfax · 11マイル先
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
被験者募集中第1相
- NEXT Oncology, Fairfax · 11マイル先
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
被験者募集中第3相
- Research Site, Fairfax · 11マイル先
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
被験者募集中第1相
- Inova Schar Cancer Institute, Falls Church · 4マイル先
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
被験者募集中第1/2相
- Research Site, Fairfax · 11マイル先
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
被験者募集中第1相
- Normunity Investigational Site, Fairfax · 11マイル先
A Study of PHST001 in Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology - Virginia, Fairfax · 11マイル先
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11マイル先
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
被験者募集中第1/2相
- USOR Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
被験者募集中第3相
- Research Site, Falls Church · 4マイル先
- Research Site, Fairfax · 11マイル先
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
被験者募集中第2相
- 522, Fairfax · 11マイル先
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- USO-Virginia Cancer Specialists, PC, Fairfax · 11マイル先
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
被験者募集中第1/2相
- NEXT Oncology Virginia, Fairfax · 11マイル先
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- NEXT, Fairfax · 11マイル先
A Study of LY4175408 in Participants With Advanced Cancer
被験者募集中第1相
- NEXT Virginia, Fairfax · 11マイル先
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
被験者募集中第1相
- NEXT Texas LLC - Virginia, Fairfax · 11マイル先
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
被験者募集中第1相
- Dren Investigational Site, Fairfax · 11マイル先
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
被験者募集中第2相
- Virginia Cancer Specialists, P.C., Fairfax · 11マイル先
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
被験者募集中第1相
- Virginia Cancer Specialists, Fairfax · 11マイル先
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
被験者募集中第1/2相
- Virginia Cancer Specialists, Fairfax · 11マイル先
他の都市における子宮内膜がんの試験
- Houston, TX68件の研究
- New York City, NY52件の研究
- Boston, MA50件の研究
- Nashville, TN38件の研究
- Los Angeles, CA34件の研究
- St. Louis, MO29件の研究
- Philadelphia, PA28件の研究
- San Antonio, TX27件の研究
- Chicago, IL25件の研究
- Columbus, OH25件の研究
- Queens, NY25件の研究
- Oklahoma City, OK25件の研究
Arlingtonにおける他の研究
- 非小細胞肺癌104件の研究
- 転移性癌53件の研究
- 大腸癌52件の研究
- がん（全種類）48件の研究
- 乳がん46件の研究
- 卵巣がん46件の研究
- 肺がん41件の研究
- 膵臓がん33件の研究
- 頭頸部扁平上皮癌26件の研究
- 小細胞肺がん23件の研究
- トリプルネガティブ乳がん20件の研究
- 胃癌20件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。